Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 125

1.

Efficacy of stem cell therapy in ambulatory and nonambulatory children with Duchenne muscular dystrophy - Phase I-II.

Dai A, Baspinar O, Yeşilyurt A, Sun E, Aydemir Çİ, Öztel ON, Capkan DU, Pinarli F, Agar A, Karaöz E.

Degener Neurol Neuromuscul Dis. 2018 Oct 26;8:63-77. doi: 10.2147/DNND.S170087. eCollection 2018.

2.

Human Adipose-Derived CD146+ Stem Cells Increase Life Span of a Muscular Dystrophy Mouse Model More Efficiently than Mesenchymal Stromal Cells.

Gomes JP, Coatti GC, Valadares MC, Assoni AF, Pelatti MV, Secco M, Zatz M.

DNA Cell Biol. 2018 Sep;37(9):798-804. doi: 10.1089/dna.2018.4158. Epub 2018 Jul 30.

PMID:
30059260
3.

A Muscle Stem Cell Support Group: Coordinated Cellular Responses in Muscle Regeneration.

Wosczyna MN, Rando TA.

Dev Cell. 2018 Jul 16;46(2):135-143. doi: 10.1016/j.devcel.2018.06.018. Review.

PMID:
30016618
4.

Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy.

Bier A, Berenstein P, Kronfeld N, Morgoulis D, Ziv-Av A, Goldstein H, Kazimirsky G, Cazacu S, Meir R, Popovtzer R, Dori A, Brodie C.

Biomaterials. 2018 Aug;174:67-78. doi: 10.1016/j.biomaterials.2018.04.055. Epub 2018 May 3.

PMID:
29783118
5.

Aggregate mesenchymal stem cell delivery ameliorates the regenerative niche for muscle repair.

Ruehle MA, Stevens HY, Beedle AM, Guldberg RE, Call JA.

J Tissue Eng Regen Med. 2018 Aug;12(8):1867-1876. doi: 10.1002/term.2707. Epub 2018 Jun 25.

PMID:
29774991
6.

Muscle Stem/Progenitor Cells and Mesenchymal Stem Cells of Bone Marrow Origin for Skeletal Muscle Regeneration in Muscular Dystrophies.

Klimczak A, Kozlowska U, Kurpisz M.

Arch Immunol Ther Exp (Warsz). 2018 Oct;66(5):341-354. doi: 10.1007/s00005-018-0509-7. Epub 2018 Mar 13. Review.

7.

Killing two birds with one stone: The multifunctional roles of mesenchymal stem cells in the treatment of neurodegenerative and muscle diseases.

Lee NK, Na DL, Chang JW.

Histol Histopathol. 2018 Jul;33(7):629-638. doi: 10.14670/HH-11-951. Epub 2017 Nov 30. Review.

PMID:
29188600
8.

Can Human Embryonic Stem Cell-Derived Stromal Cells Serve a Starting Material for Myoblasts?

Ando Y, Saito M, Machida M, Yoshida-Noro C, Akutsu H, Takahashi M, Toyoda M, Umezawa A.

Stem Cells Int. 2017;2017:7541734. doi: 10.1155/2017/7541734. Epub 2017 Jun 15.

9.

Dental stem cells: recent progresses in tissue engineering and regenerative medicine.

Botelho J, Cavacas MA, Machado V, Mendes JJ.

Ann Med. 2017 Dec;49(8):644-651. doi: 10.1080/07853890.2017.1347705. Epub 2017 Jul 12. Review.

PMID:
28649865
10.

Identification and Function of Fibrocytes in Skeletal Muscle Injury Repair and Muscular Dystrophy.

Wang X, Zhao W, Ransohoff RM, Zhou L.

J Immunol. 2016 Dec 15;197(12):4750-4761. Epub 2016 Nov 9.

11.

Menstrual Blood-Derived Stem Cells: In Vitro and In Vivo Characterization of Functional Effects.

Rodrigues MC, Lippert T, Nguyen H, Kaelber S, Sanberg PR, Borlongan CV.

Adv Exp Med Biol. 2016;951:111-121. Review.

PMID:
27837558
12.

In vivo myomaker-mediated heterologous fusion and nuclear reprogramming.

Mitani Y, Vagnozzi RJ, Millay DP.

FASEB J. 2017 Jan;31(1):400-411. doi: 10.1096/fj.201600945R. Epub 2016 Oct 17.

13.

Different Donors Mesenchymal Stromal Cells Secretomes Reveal Heterogeneous Profile of Relevance for Therapeutic Use.

Assoni A, Coatti G, Valadares MC, Beccari M, Gomes J, Pelatti M, Mitne-Neto M, Carvalho VM, Zatz M.

Stem Cells Dev. 2017 Feb 1;26(3):206-214. doi: 10.1089/scd.2016.0218. Epub 2016 Oct 20.

PMID:
27762666
14.

Not All Pericytes Are Born Equal: Pericytes from Human Adult Tissues Present Different Differentiation Properties.

Vezzani B, Pierantozzi E, Sorrentino V.

Stem Cells Dev. 2016 Aug 22. [Epub ahead of print]

PMID:
27549576
15.

Anti-apoptotic Effects of Human Wharton's Jelly-derived Mesenchymal Stem Cells on Skeletal Muscle Cells Mediated via Secretion of XCL1.

Kwon S, Ki SM, Park SE, Kim MJ, Hyung B, Lee NK, Shim S, Choi BO, Na DL, Lee JE, Chang JW.

Mol Ther. 2016 Sep;24(9):1550-60. doi: 10.1038/mt.2016.125. Epub 2016 Jun 23.

16.

Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure.

Pelatti MV, Gomes JP, Vieira NM, Cangussu E, Landini V, Andrade T, Sartori M, Petrus L, Zatz M.

Stem Cell Rev. 2016 Aug;12(4):448-53. doi: 10.1007/s12015-016-9659-3.

PMID:
27193781
17.

Activation of Wnt3a signaling promotes myogenic differentiation of mesenchymal stem cells in mdx mice.

Shang YC, Wang SH, Xiong F, Peng FN, Liu ZS, Geng J, Zhang C.

Acta Pharmacol Sin. 2016 Jul;37(7):873-81. doi: 10.1038/aps.2016.38. Epub 2016 May 2.

18.

Generation and Characterization of a MYF5 Reporter Human iPS Cell Line Using CRISPR/Cas9 Mediated Homologous Recombination.

Wu J, Hunt SD, Xue H, Liu Y, Darabi R.

Sci Rep. 2016 Jan 5;6:18759. doi: 10.1038/srep18759.

19.

Aging induced loss of stemness with concomitant gain of myogenic properties of a pure population of CD34(+)/CD45(-) muscle derived stem cells.

Bose B, Shenoy PS.

Int J Biochem Cell Biol. 2016 Jan;70:1-12. doi: 10.1016/j.biocel.2015.10.009. Epub 2015 Oct 13.

PMID:
26655331
20.

Flk-1⁺Sca-1⁻ mesenchymal stem cells: functional characteristics in vitro and regenerative capacity in vivo.

Li Y, Pan E, Wang Y, Zhu X, Wei A.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):9875-88. eCollection 2015.

Supplemental Content

Loading ...
Support Center